In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (6)
- ITM receives Complete Response Letter for ITM-11 AuntMinnie · 15h ago
- 177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment cancernetwork.com · 15h ago
- ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11) WBOC TV · 15h ago
- ITM Says FDA Issues Complete Response Letter For 177Lu-Edotreotide (ITM-11) NDA TradingView · 15h ago
- ITM cancer drug spurned by FDA over manufacturing qualms Fierce Pharma · 15h ago
- In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment STAT · 15h ago broke it first
Related trends
Trump media company announces a massive loss and new turnaround effort
Trump Media & Technology Group reports a second-quarter loss of $238 million amid declining digital assets and falling cryptocurrency values.
Wall Street giants partner with Nvidia on $500bn AI financing deal
A $500 billion AI financing pact linking Nvidia with Wall Street giants is dominating business news today.
Defaults Expose Cracks in High-Flying Private Credit
Private‑credit markets clash with optimism as Bloomberg touts rebounds while WSJ warns loan health is deteriorating.
Volkswagen Atlas Cross Sport (2027)
Volkswagen rolls out a more powerful 2027 Atlas Cross Sport, yet omits hybrid tech and even basic towing capacity.
Lenders scrutinize US data center financing as community opposition builds
Lenders now price community pushback as a credit risk in U.S. data center financing, reshaping investor strategies.
Boeing to Sell 3 Autonomous Flight Subsidiaries
Boeing exits eVTOL market by transferring three autonomous flight units to Archer Aviation, securing a new equity partnership